Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hopper Health is a digital-first primary care and health navigation platform specifically designed to meet the unique healthcare needs of neurodivergent adults, including those with autism, ADHD, OCD, and Tourette's syndrome. Founded in 2022, the company addresses systemic barriers in the healthcare system, such as sensory sensitivities and diagnostic overshadowing, which often lead to care avoidance in the neurodivergent population. The platform connects members with primary care clinicians and peer navigators who have lived experience or specialized training in neurodivergent-competent care, facilitating extended virtual visits and tailored health management plans. Hopper Health operates on a subscription-based membership model, offering a comprehensive suite of services that adapt to the communication and information-processing needs of its users. The company emphasizes identity-centered care and health equity, aiming to improve long-term outcomes for a population that is historically underserved by traditional medical providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hopper.